...
首页> 外文期刊>Journal of Oral and Maxillofacial Surgery >Management of central giant cell granuloma of mandible using intralesional corticosteroids: case report and review of literature.
【24h】

Management of central giant cell granuloma of mandible using intralesional corticosteroids: case report and review of literature.

机译:使用病灶内皮质类固醇治疗下颌骨中央巨细胞肉芽肿:病例报告和文献复习。

获取原文
获取原文并翻译 | 示例
           

摘要

The World Health Organization has defined central giant cell granuloma (CGCG) as "an intraosseous lesion consisting of cellular fibrous tissue containing multiple foci of hemorrhage, aggregations of multinu-cleated giant cells, and occasionally, trabeculae of woven bone."1 The lesion was first described in 1953 by Jaffe and termed a giant cell reparative granuloma.1'2 He further opined that these lesions were not true neoplasms but, rather, represented a local reparative reaction.3 Subsequent experience revealed that the clinical behavior of the lesion is largely inconsistent with a reparative process, and the term "reparative" was dropped.1 Currently, and despite the current World Health Organization definition, the true nature of the lesion is unknown.
机译:世界卫生组织将中央巨细胞肉芽肿(CGCG)定义为“骨内病变,由含有多个出血灶的细胞纤维组织,多核巨细胞聚集,偶尔有编织骨小梁组成。” 1病变为1953年由Jaffe首次描述,被称为巨细胞修复性肉芽肿。1'2他进一步认为这些病变不是真正的肿瘤,而是局部的修复反应。3随后的经验表明,病变的临床行为在很大程度上与修复过程不一致,因此放弃了“修复”一词。1目前,尽管有世界卫生组织的当前定义,病变的真实性质尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号